WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 骨代謝の生理学および生化学的マーカー bone physiology and biochemical markers of bone turnover
2. 有毛細胞白血病の臨床的特徴および診断 clinical features and diagnosis of hairy cell leukemia
3. ゴーシェ病：病因、臨床症状、および診断 gaucher disease pathogenesis clinical manifestations and diagnosis
4. 非甲状腺疾患における甲状腺機能 thyroid function in nonthyroidal illness
5. 急性冠症候群：β遮断剤の役割 acute myocardial infarction role of beta blocker therapy

Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes.

Vogel AP1, Folker J, Poole ML.
The Cochrane database of systematic reviews.Cochrane Database Syst Rev.2014 Oct 28;10:CD008953. doi: 10.1002/14651858.CD008953.pub2.
BACKGROUND: Hereditary ataxia syndromes can result in significant speech impairment, a symptom thought to be responsive to treatment. The type of speech impairment most commonly reported in hereditary ataxias is dysarthria. Dysarthria is a collective term referring to a group of movement disorders a
PMID 25348587

Secondary amenorrhea in a woman with spinocerebellar degeneration treated with thyrotropin-releasing hormone: a case report and in vitro analysis.

Kanasaki H1, Oride A, Mijiddorj T, Purwana I, Miyazaki K.
Journal of medical case reports.J Med Case Rep.2011 Dec 9;5:567. doi: 10.1186/1752-1947-5-567.
INTRODUCTION: While thyrotropin-releasing hormone is known to be a prolactin-release stimulating factor, thyrotropin-releasing hormone-tartrate and its derivative, taltirelin hydrate, are used for the treatment of spinocerebellar degeneration, a degenerative disease characterized mainly by motor ata
PMID 22152284

NP-647, a novel TRH analogue: investigating physicochemical parameters critical for its oral and parenteral delivery.

Khomane K1, Kumar L, Meena CL, Jain R, Bansal A.
International journal of pharmaceutics.Int J Pharm.2011 Mar 15;406(1-2):21-30. doi: 10.1016/j.ijpharm.2010.12.025. Epub 2010 Dec 24.
NP-647 (L-pGlu-(2-propyl)-L-His-L-ProNH(2)) is a novel thyrotropin releasing hormone (TRH) analogue, with potential antiepileptic activity. In the present study, the physicochemical parameters of NP-647, including its solid state properties, dissociation constant, partition coefficient, solubility (
PMID 21185925